The Oligonucleotide Therapeutics market was valued at USD 18.19 Billion in 2021 and is expected to reach USD 51.35 Billion by 2029, growing at a CAGR of 13.85% (2022-2029). Get insights on trends, segmentation, and key players with Data Bridge Market